With more than 600k average monthly users on the HotCopper forums, each and every discussion can move markets. That’s why ...

We think all investors should try to buy and hold high quality multi-year winners. And highest quality companies can see their share prices grow by huge amounts. Don't believe it? Then look at the ...

Compumedics Limited’s (ASX:CMP) most recent return on equity was a substandard 7.53% relative to its industry performance of 12.19% over the past year. Though CMP’s recent performance is underwhelming ...

Compumedics delivers breakout performance in FY25 with record revenue and sales orders, a return to profitability, and accelerating growth in the US and SaaS segments. Compumedics (ASX:CMP) said the ...

Compumedics has received FDA approval to market Falcon, its second home sleep testing solution in the US, with potential to substantially boost its revenue. Falcon to complement Compumedics Somfit ...

Compumedics Limited (AU:CMP) has released an update. Compumedics Limited projects a record-breaking year with over $50 million in sales orders and at least $46 million in revenue for FY24, driven by ...

Compumedics (ASX:CMP) said the last financial year laid a stronger more scalable business model for FY26 and beyond with record sales orders of $63.4 million, up 22% on FY24. EBITDA increased to ~$3m, ...